These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22986435)

  • 41. Bullous pemphigoid antigen 1 isoforms: potential new target autoantigens in multiple sclerosis?
    Laffitte E; Burkhard PR; Fontao L; Jaunin F; Saurat JH; Chofflon M; Borradori L
    Br J Dermatol; 2005 Mar; 152(3):537-40. PubMed ID: 15787824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lessons from studies of antigen-specific T cell responses in Multiple Sclerosis.
    Martin R; Bielekova B; Gran B; McFarland HF
    J Neural Transm Suppl; 2000; (60):361-73. PubMed ID: 11205154
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biological markers for multiple sclerosis.
    Lutterotti A; Berger T; Reindl M
    Curr Med Chem; 2007; 14(18):1956-65. PubMed ID: 17691938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MHC-restricted autoantigen-reactive T cell clones in multiple sclerosis.
    Rohowsky-Kochan C; Troiano R; Cook SD
    J Immunogenet; 1989 Dec; 16(6):437-44. PubMed ID: 2484313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autoantibodies against alpha B-crystallin, a candidate autoantigen in multiple sclerosis, are part of a normal human immune repertoire.
    van Noort JM; Verbeek R; Meilof JF; Polman CH; Amor S
    Mult Scler; 2006 Jun; 12(3):287-93. PubMed ID: 16764341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The proteasome is a major autoantigen in multiple sclerosis.
    Mayo I; Arribas J; Villoslada P; Alvarez DoForno R; Rodríguez-Vilariño S; Montalban X; De Sagarra MR; Castaño JG
    Brain; 2002 Dec; 125(Pt 12):2658-67. PubMed ID: 12429593
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High prevalence of anti-alpha-crystallin antibodies in multiple sclerosis: correlation with severity and activity of disease.
    Agius MA; Kirvan CA; Schafer AL; Gudipati E; Zhu S
    Acta Neurol Scand; 1999 Sep; 100(3):139-47. PubMed ID: 10478576
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anoctamin 2 identified as an autoimmune target in multiple sclerosis.
    Ayoglu B; Mitsios N; Kockum I; Khademi M; Zandian A; Sjöberg R; Forsström B; Bredenberg J; Lima Bomfim I; Holmgren E; Grönlund H; Guerreiro-Cacais AO; Abdelmagid N; Uhlén M; Waterboer T; Alfredsson L; Mulder J; Schwenk JM; Olsson T; Nilsson P
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2188-93. PubMed ID: 26862169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quantification of self-recognition in multiple sclerosis by single-cell analysis of cytokine production.
    Pelfrey CM; Rudick RA; Cotleur AC; Lee JC; Tary-Lehmann M; Lehmann PV
    J Immunol; 2000 Aug; 165(3):1641-51. PubMed ID: 10903775
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Self-determinants in autoimmune demyelinating disease: changes in T- cell response specificity.
    Tuohy VK; Fritz RB; Ben-Nun A
    Curr Opin Immunol; 1994 Dec; 6(6):887-91. PubMed ID: 7536010
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS.
    Methner A; Zipp F
    Nat Rev Neurol; 2013 Feb; 9(2):72-3. PubMed ID: 23338282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Laminin-induced aggregation of the inwardly rectifying potassium channel, Kir4.1, and the water-permeable channel, AQP4, via a dystroglycan-containing complex in astrocytes.
    Guadagno E; Moukhles H
    Glia; 2004 Aug; 47(2):138-49. PubMed ID: 15185393
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epstein-Barr and other viral mimicry of autoantigens, myelin and vitamin D-related proteins and of EIF2B, the cause of vanishing white matter disease: massive mimicry of multiple sclerosis relevant proteins by the Synechococcus phage.
    Carter CJ
    Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):21-35. PubMed ID: 21486137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oligodendrocytes control potassium accumulation in white matter and seizure susceptibility.
    Larson VA; Mironova Y; Vanderpool KG; Waisman A; Rash JE; Agarwal A; Bergles DE
    Elife; 2018 Mar; 7():. PubMed ID: 29596047
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Do human T-lymphotrophic viruses (HTLVs) and other enveloped viruses induce autoimmunity in multiple sclerosis?
    Dalgleish AG; Fazakerley JK; Webb HE
    Neuropathol Appl Neurobiol; 1987; 13(4):241-50. PubMed ID: 2821421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The oligodendroglial cell: biology and immunology and relationship to multiple sclerosis.
    Bartlett PF; Mackay IR
    J Clin Lab Immunol; 1983 May; 11(1):1-7. PubMed ID: 6348293
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis.
    Bernard CC; Johns TG; Slavin A; Ichikawa M; Ewing C; Liu J; Bettadapura J
    J Mol Med (Berl); 1997 Feb; 75(2):77-88. PubMed ID: 9083925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The ups and downs of EAE.
    Heber-Katz E
    Int Rev Immunol; 1993; 9(4):277-85. PubMed ID: 7683709
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunopathological recognition of autoantigens in multiple sclerosis.
    Bernard CC; de Rosbo NK
    Acta Neurol (Napoli); 1991 Apr; 13(2):171-8. PubMed ID: 1891982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.